Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-05-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-023-00859-x |
_version_ | 1797811965156917248 |
---|---|
author | I. Vaxman S. K. Kumar F. Buadi M. Q. Lacy D. Dingli S. Hayman T. Kourelis R. Warsame Y. Hwa A. Fonder M. Hobbs E. Muchtar N. Leung P. Kapoor R. Go Y. Lin W. Gonsalves M. Siddiqui R. A. Kyle S. V. Rajkumar M. A. Gertz A. Dispenzieri |
author_facet | I. Vaxman S. K. Kumar F. Buadi M. Q. Lacy D. Dingli S. Hayman T. Kourelis R. Warsame Y. Hwa A. Fonder M. Hobbs E. Muchtar N. Leung P. Kapoor R. Go Y. Lin W. Gonsalves M. Siddiqui R. A. Kyle S. V. Rajkumar M. A. Gertz A. Dispenzieri |
author_sort | I. Vaxman |
collection | DOAJ |
first_indexed | 2024-03-13T07:30:34Z |
format | Article |
id | doaj.art-744df0ab94de46598b60fe543ab0afab |
institution | Directory Open Access Journal |
issn | 2044-5385 |
language | English |
last_indexed | 2024-03-13T07:30:34Z |
publishDate | 2023-05-01 |
publisher | Nature Publishing Group |
record_format | Article |
series | Blood Cancer Journal |
spelling | doaj.art-744df0ab94de46598b60fe543ab0afab2023-06-04T11:06:55ZengNature Publishing GroupBlood Cancer Journal2044-53852023-05-011311410.1038/s41408-023-00859-xDaratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic ExperienceI. Vaxman0S. K. Kumar1F. Buadi2M. Q. Lacy3D. Dingli4S. Hayman5T. Kourelis6R. Warsame7Y. Hwa8A. Fonder9M. Hobbs10E. Muchtar11N. Leung12P. Kapoor13R. Go14Y. Lin15W. Gonsalves16M. Siddiqui17R. A. Kyle18S. V. Rajkumar19M. A. Gertz20A. Dispenzieri21Division of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo Clinichttps://doi.org/10.1038/s41408-023-00859-x |
spellingShingle | I. Vaxman S. K. Kumar F. Buadi M. Q. Lacy D. Dingli S. Hayman T. Kourelis R. Warsame Y. Hwa A. Fonder M. Hobbs E. Muchtar N. Leung P. Kapoor R. Go Y. Lin W. Gonsalves M. Siddiqui R. A. Kyle S. V. Rajkumar M. A. Gertz A. Dispenzieri Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience Blood Cancer Journal |
title | Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience |
title_full | Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience |
title_fullStr | Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience |
title_full_unstemmed | Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience |
title_short | Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience |
title_sort | daratumumab carfilzomib and pomalidomide for the treatment of poems syndrome the mayo clinic experience |
url | https://doi.org/10.1038/s41408-023-00859-x |
work_keys_str_mv | AT ivaxman daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT skkumar daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT fbuadi daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT mqlacy daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT ddingli daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT shayman daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT tkourelis daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT rwarsame daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT yhwa daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT afonder daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT mhobbs daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT emuchtar daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT nleung daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT pkapoor daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT rgo daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT ylin daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT wgonsalves daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT msiddiqui daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT rakyle daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT svrajkumar daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT magertz daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience AT adispenzieri daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience |